Karim Saad Temsamani is CEO at Cardlytics, Inc. (CDLX). They have made 8 open-market trades across 1 company since 2023, most recently 2024-06-04.
CIK 0001944491
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CDLX | 385,530 | $810K |
Shares reported on the most recent Form 4, priced at the 2024-06-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CDLX | SELL | 2024-06-04 | 2024-06-04 | $8.66 | $747K | -3.7% | -4.9% | -58.8% |
| CDLX | SELL | 2024-04-01 | 2024-04-02 | $13.69 | $894K | +1.3% | +4.3% | -39.7% |
| CDLX | SELL | 2024-03-04 | 2024-03-05 | $7.89 | $545K | +100.6% | +80.8% | +18.1% |
| CDLX | SELL | 2024-01-03 | 2024-01-03 | $7.77 | $484K | -14.5% | -2.2% | +77.7% |
| CDLX | SELL | 2023-12-05 | 2023-12-05 | $8.21 | $664K | +4.5% | -10.5% | -7.0% |
| CDLX | SELL | 2023-10-02 | 2023-10-03 | $14.31 | $816K | -15.2% | +1.5% | -31.6% |
| CDLX | SELL | 2023-09-07 | 2023-09-11 | $17.30 | $5.8M | -17.2% | -27.5% | -54.4% |
| CDLX | SELL | 2023-07-03 | 2023-07-05 | $6.13 | $314K | +51.8% | +137.2% | +120.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.